TNFAIP3, the gene encoding A20, has been documented to be an anti-inflammatory and immune factor [51] and expressed increased abnormally in many types of tumor cells and tissues, which was closely associated with the progression, therapy and prognosis of cancer [52, 53]. This evidence concerns the gene TNFAIP3 and cancer.